Literature DB >> 26002022

The intestinal microbiome in spondyloarthritis.

Tejpal Gill1, Mark Asquith, James T Rosenbaum, Robert A Colbert.   

Abstract

PURPOSE OF REVIEW: Microbial dysbiosis in the gut is emerging as a common component in various inflammatory disorders including spondyloarthritis (SpA). The depth of this influence has begun to be realized with next-generation sequencing of the gut microbiome providing unbiased assessment of previously uncharted bacterial populations. RECENT
FINDINGS: Decreased numbers of Firmicutes, a major phyla of gut commensals, especially the species Faecalibacterium prausnitzii and Clostridium leptum have been found in various inflammatory disorders including SpA and inflammatory bowel disease (IBD), and could be an important link between SpA and gut inflammation. Multiple studies in ankylosing spondylitis, psoriatic arthritis, juvenile SpA, and animal models of SpA are revealing common bacterial associations among these diseases as well as IBD.
SUMMARY: We are beginning to appreciate the complex relationship between the gut microbiome and host immune regulation and dysregulation in health and disease. Potentially important differences have been revealed in SpA, but cause and effect relationships remain far from established. Many critical questions remain to be answered before we can apply new knowledge to improve therapeutics in SpA.

Entities:  

Mesh:

Year:  2015        PMID: 26002022      PMCID: PMC4489849          DOI: 10.1097/BOR.0000000000000187

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  64 in total

Review 1.  Microbiota restoration: natural and supplemented recovery of human microbial communities.

Authors:  Gregor Reid; Jessica A Younes; Henny C Van der Mei; Gregory B Gloor; Rob Knight; Henk J Busscher
Journal:  Nat Rev Microbiol       Date:  2010-11-29       Impact factor: 60.633

2.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

3.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

Review 4.  Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk.

Authors:  Elaine Holmes; Jia V Li; Julian R Marchesi; Jeremy K Nicholson
Journal:  Cell Metab       Date:  2012-11-07       Impact factor: 27.287

5.  Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.

Authors:  Nagendra Singh; Ashish Gurav; Sathish Sivaprakasam; Evan Brady; Ravi Padia; Huidong Shi; Muthusamy Thangaraju; Puttur D Prasad; Santhakumar Manicassamy; David H Munn; Jeffrey R Lee; Stefan Offermanns; Vadivel Ganapathy
Journal:  Immunity       Date:  2014-01-09       Impact factor: 31.745

6.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.

Authors:  Ben P Willing; Johan Dicksved; Jonas Halfvarson; Anders F Andersson; Marianna Lucio; Zongli Zheng; Gunnar Järnerot; Curt Tysk; Janet K Jansson; Lars Engstrand
Journal:  Gastroenterology       Date:  2010-10-08       Impact factor: 22.682

7.  Ankylosing spondylitis: klebsiella and HL-A B27.

Authors:  R Ebringer; D Cooke; D R Cawdell; P Cowling; A Ebringer
Journal:  Rheumatol Rehabil       Date:  1977-08

8.  Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation.

Authors:  Francesco Ciccia; Antonina Accardo-Palumbo; Aroldo Rizzo; Giuliana Guggino; Stefania Raimondo; AnnaRita Giardina; Alessandra Cannizzaro; Robert A Colbert; Riccardo Alessandro; Giovanni Triolo
Journal:  Ann Rheum Dis       Date:  2013-06-05       Impact factor: 19.103

9.  The gut microbiota as an environmental factor that regulates fat storage.

Authors:  Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

10.  Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

Authors:  Stephan R Targan; Carol J Landers; Huiying Yang; Michael J Lodes; Yingzi Cong; Konstantinos A Papadakis; Eric Vasiliauskas; Charles O Elson; Robert M Hershberg
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

View more
  37 in total

Review 1.  Dendritic cells in the pathogenesis of ankylosing spondylitis and axial spondyloarthritis.

Authors:  Gleb Slobodin; Itzhak Rosner; Aharon Kessel
Journal:  Clin Rheumatol       Date:  2018-12-05       Impact factor: 2.980

2.  The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.

Authors:  Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Nimman Satumtira; Martha L Dorris; Mylinh T Nguyen; Robert E Hammer; Tri M Tran; Robert A Colbert; Joel D Taurog; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2017-02-10       Impact factor: 5.911

Review 3.  Current concepts and unmet needs in psoriatic arthritis.

Authors:  Farrouq Mahmood; Laura C Coates; Philip S Helliwell
Journal:  Clin Rheumatol       Date:  2017-11-13       Impact factor: 2.980

Review 4.  Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.

Authors:  Eric Gracey; Lars Vereecke; Dermot McGovern; Mareike Fröhling; Georg Schett; Silvio Danese; Martine De Vos; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2020-07-13       Impact factor: 20.543

5.  Henoch-Schonlein purpura associated with HLA-B27 positive axial spondyloarthritis in a young man.

Authors:  Kevin John John; Mohammad Sadiq; Meera Thomas; Vijay Prakash Turaka
Journal:  BMJ Case Rep       Date:  2019-05-24

6.  Effect of probiotics on clinical and immune parameters in enthesitis-related arthritis category of juvenile idiopathic arthritis.

Authors:  A Shukla; P Gaur; A Aggarwal
Journal:  Clin Exp Immunol       Date:  2016-09       Impact factor: 4.330

7.  Gut microbiome in children with enthesitis-related arthritis in a developing country and the effect of probiotic administration.

Authors:  A Aggarwal; A N Sarangi; P Gaur; A Shukla; R Aggarwal
Journal:  Clin Exp Immunol       Date:  2016-12-12       Impact factor: 4.330

8.  Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children.

Authors:  Alexandra Paun; Christopher Yau; Shahab Meshkibaf; Michelle C Daigneault; Leili Marandi; Steven Mortin-Toth; Amit Bar-Or; Emma Allen-Vercoe; Philippe Poussier; Jayne S Danska
Journal:  Sci Immunol       Date:  2019-02-01

9.  Distinct immune signatures in the colon of Crohn's disease and ankylosing spondylitis patients in the absence of inflammation.

Authors:  Elliott T J Dunn; Edward S Taylor; Simon Stebbings; Michael Schultz; A Grant Butt; Roslyn A Kemp
Journal:  Immunol Cell Biol       Date:  2015-12-09       Impact factor: 5.126

Review 10.  Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases.

Authors:  Yanfeng Bao; Chen Dong; Juan Ji; Zhifeng Gu
Journal:  Clin Rheumatol       Date:  2020-06-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.